CyGenica
PrivateLast Round
Seed
Jun 8, 2021
Total Funding Raised
$3.56M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
CyGenica is a biotechnology company that provides a non-viral, non-toxic platform for safe and targeted molecular delivery for intracellular therapeutic development.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CyGenica Comparables
Compare CyGenica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoSyrinx | 86% | |
| Sapreme Technologies BV | 83% | |
| iDEL Therapeutics | 82% | |
CyGenica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 8, 2021 |
CyGenica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Voyagers.io | Seed |
| Biotechnology Industry Research Assistance Council | Grant |
| SOSV | Convertible Debt, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Monthly visitors increased 2154% MoM, reaching 1.6K.
- Apr 18, 2026
Monthly visitors increased 355% MoM.
CyGenica Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CyGenica's valuation, stock price, and market status.